|Ms. Belen Garijo Lopez M.D.||Chair of Exec. Board & CEO||5.72M||N/A||1960|
|Dr. Marcus Kuhnert||CFO & Member of Exec. Board||4.48M||N/A||1968|
|Dr. Kai Beckmann||CEO of Electronics & Member of the Exec. Board||4.51M||N/A||1965|
|Mr. Peter Guenter||CEO of Healthcare Bus. & Member of Exec. Board||2.22M||N/A||1962|
|Dr. Matthias J. Heinzel||CEO of Life Science Sector & Member of Exec. Board||1.68M||N/A||1967|
|Mr. Gerhard Schmitz||Head of Global Accounting||N/A||N/A||1963|
|Mr. Dirk Toepfer||Chief Information Officer||N/A||N/A||N/A|
|Mr. Constantin Fest||Head of Investor Relations||N/A||N/A||1977|
|Dr. Friederike Rotsch||Group Gen. Counsel and Head of Group Legal & Compliance||N/A||N/A||1972|
|Ms. Barbara Weiland||Chief Compliance Officer||N/A||N/A||1974|
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
MERCK Kommanditgesellschaft auf Aktien’s ISS governance QualityScore as of 1 June 2022 is 9. The pillar scores are Audit: 3; Board: 7; Shareholder rights: 10; Compensation: 5.